Umckalor. Designed to reduce the symptoms of acute bronchitis, coughing up aids.
Umckalor 20 mg film-coated tablets
Geranium root extract liquid, dried
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Always take this medicine exactly as described in this leaflet or as directed by your doctor or pharmacist.
- Keep this leaflet You may need to read it.
- If you want more information or advice, ask your pharmacist.
- If you experience any serious side effects (even if it is not listed), ask your doctor or pharmacist.See. Chapter 4
- If within 7 days of your being improved or even worse, see your doctor.
What is in this leaflet?
- What is Umckalor is and what it is used for
- Before you Umckalor
- How Umckalor
- Possible side effects
- How to store Umckalor
- Contents of the pack and other information
- What is Umckalor is and what it is used for
Pharmaco group
Expectorant drugs improve
Therapeutic indications
Umckalor is a herbal medicine to reduce the symptoms of acute bronchitis, coughing up aids.
- Before you Umckalor
Umckalor Do not
- If you are allergic Pelargonium sidoides extract or any of the other ingredients of this medicine (listed in section 6);
- If you have severe liver problems, because there is not enough experience.
Warnings and Precautions
Check with your doctor or pharmacist before taking Umckalor:
- If you have any type of liver disorders.
If your condition does not improve within 7 days, the temperature takes a few days, get any kind of liver disorder, suffer from shortness of breath or ATKO sputum with blood, contact your doctor.
Other medicines and Umckalor
If you are taking or have recently taken any other medicines, or because you are not sure, talk to your doctor or pharmacist.
Drug-drug interactions have been observed to date.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, you think you may be pregnant, or are planning to become pregnant before taking this medicine, talk to your doctor or pharmacist.
During pregnancy and lactation Umckalor should not be used because there is not enough experience.
Driving and using machines
Umckalor ability to drive and use machines.
Umckalor contains lactose monohydrate
If your doctor has told you that you have intolerance to some sugars, contact your doctor before taking this medicine.
- How Umckalor
Always take this medicine exactly as described in this leaflet or as directed by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
Umckalor are film-coated tablet to be taken orally.
The usual dose is:
- Adults and children over 12 years of age take 1 tablet 3 times a day (morning, afternoon and evening).
Umckalor use whole with a little water.
duration of use
Once symptoms of the disease is reduced, it is recommended to continue taking this medicine for several days in order to avoid relapse. The duration of treatment should not be longer than 3 weeks.
If you take a large dose Umckalor?
In case of overdose Umckalor no symptoms so far not been observed.
If you forget to Umckalor
Do not take a double dose to make up for a missed dose. Next Umckalor use as described in this leaflet.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
- POSSIBLE SIDE EFFECTS
This medicine, like all others, can cause side effects, although not everybody gets them.
The side effects include all reactions observed during treatment Umckalor time, even those resulting from administration of a higher dose or for a longer period of time.
Uncommon (occurring in less than 1 in 100 but more than 1 out of 1,000 people)
Gastrointestinal ailments.
Rare (occurring in less than 1 in 1,000, but more than 1 in 10,000 treated people)
Minor bleeding from the nose.
Minor bleeding from the gums.
Hypersensitivity reactions.
Not known (can not be estimated from the available data)
But what kind of liver disorders; a causal relationship between them and the medicine has not been proven.
Notification of side effects
If you experience side effects, including not listed, please tell your doctor or pharmacist. The side effects can also report directly by filling out the web site www.vvkt.lt the form by mail to the State Medicines Control Agency under the Lithuanian Ministry of Health, Žirmūnų g. 139A, LT 09120 Vilnius Tel: 8 800 73 568, fax 8 800 20131 or e-mail. Email NepageidaujamaR@vvkt.lt. When reporting side effects you can help us to get more information about the safety of the medicine.
- How to store Umckalor
Keep this medicine out of the sight and reach of children place.
On the carton and blister after EXP after the expiry date of this medicine. The expiry refers to the last day of the month.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. How to dispose of unwanted medication, ask your pharmacist. These measures will help to protect the environment.
- Contents of the pack and other information
Umckalor composition
- The active substance is a liquid geranium root extract, dried.
1 film-coated tablet contains 20 mg of Pelargonium sidoides DC., Radix (geraniums root) extract liquid, dried (1: 8 - 10). Extraction solvent: 11% (m / m) ethanol.
- Emergent material. Tablet core maltodextrin, microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, precipitated silica, magnesium stearate. Film-coating: Hypromellose 5 mPas, macrogol 1500, yellow iron oxide (E 172), red iron oxide (E172), titanium dioxide (E 171), talc, Simethicone emulsion (simethicone, methyl cellulose, sorbic acid).
Umckalor appearance and contents of the pack
Umckalor is reddish-brown, round, film-coated tablet. Umckalor packs of 15, 21, 30 or 42 film-coated tablets.
It may not be available in all packs.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
Deutsche Homöopathie-Union
DHU-Arzneimittel GmbH & Co. KG KG
Ottostraße 24, 76227 Karlsruhe, Germany
Tel. +49 721 4093 01
Fax: +49 721 4093 316
- email info@dhu.com
Brand:
Dr. Willmar Schwabe GmbH & Co. KG KG
Willmar-Schwabe-Str. 4, 76227 Karlsruhe, Germany
Tel. +49 721 4005 0
Fax: +49 721 4005 500
- email info@schwabepharma.com